INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 7.05
-0.90 (-11.32%)
At close: Aug 26, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 757.7 million as of August 26, 2026. Its market cap has increased by 76.20% in one year.
Market Cap
757.70M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.05
ChartMarket Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has increased from 452.37M to 757.70M, an increase of 67.50%. That is a compound annual growth rate of 13.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 757.70M | 98.41% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.68B |
| Circio Holding ASA | 2.60B |
| Thor Medical ASA | 2.49B |
| Nordhealth AS | 1.85B |
| ArcticZymes Technologies ASA | 1.05B |
| Vistin Pharma ASA | 855.85M |
| Omda AS | 728.02M |
| Zelluna ASA | 620.63M |